SOMX may well be a good play. Looking at the basic pps movement from approval date, the spike has dissipated and any rise from here should be more sustained based on revenues and partnerships rather than FDA hype. Had forgotten about that one, thanks for reminding.
I do none harm, I say none harm, I think none harm but wish
everybody good..." Saint Thomas More 1535.